RNA sequencing identifies fusion of the EWSR1 and YY1 genes in mesothelioma with t(14;22)(q32;q12)

Genes Chromosomes and Cancer

Volumn 52, Issue 8, 2013, Pages 733-740

  Panagopoulos, Ioannis ^a,b   Thorsen, Jim ^a,b   Gorunova, Ludmila ^a,b   Micci, Francesca ^a,b   Haugom, Lisbeth ^a,b   Davidson, Ben ^a,b   Heim, Sverre ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETININ; CYTOKERATIN 1; CYTOKERATIN 3; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; NUCLEOTIDE; PROTEIN; PROTEIN EWSR1; TRANSCRIPTION FACTOR YY1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME G BAND; CLINICAL ARTICLE; CYTOGENETICS; DNA BINDING; EXON; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FUSION GENE; GENE IDENTIFICATION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; KARYOTYPING; MALE; MESOTHELIOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; TRANSACTIVATION;

ADULT; AGED; CALMODULIN-BINDING PROTEINS; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 22; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MESOTHELIOMA; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; RNA-BINDING PROTEINS; SEQUENCE ANALYSIS, RNA; TRANSLOCATION, GENETIC; YY1 TRANSCRIPTION FACTOR;

EID: 84879252670     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22068     Document Type: Article

References (24)

1. Alex D, Lee KA. 2005. RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains. Nucleic Acids Res 33:1323-1331.
2. Atchison M, Basu A, Zaprazna K, Papasani M. 2011. Mechanisms of Yin Yang 1 in oncogenesis: The importance of indirect effects. Crit Rev Oncog 16:143-161.
3. Bianchi C, Bianchi T. 2007. Malignant mesothelioma: Global incidence and relationship with asbestos. Ind Health 45:379-387.
4. Deng Z, Cao P, Wan MM, Sui G. 2010. Yin Yang 1: A multifaceted protein beyond a transcription factor. Transcription 1:81-84.
5. Ge H, Liu K, Juan T, Fang F, Newman M, Hoeck W. 2011. FusionMap: Detecting fusion genes from next-generation sequencing data at base-pair resolution. Bioinformatics 27:1922-1928.
6. Gordon S, Akopyan G, Garban H, Bonavida B. 2006. Transcription factor YY1: Structure, function, and therapeutic implications in cancer biology. Oncogene 25:1125-1142.
7. Hassan R, Alexander R. 2005. Nonpleural mesotheliomas: Mesothelioma of the peritoneum, tunica vaginalis, and pericardium. Hematol Oncol Clin North Am 19:1067-1087, vi.
8. Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, Sam L, Barrette T, Palanisamy N, Chinnaiyan AM. 2009. Transcriptome sequencing to detect gene fusions in cancer. Nature 458:97-101.
9. Mandahl N. 2001. Methods in solid tumour cytogenetics. In: Rooney DE, editor. Human Cytogenetics: Malignancy and Acquired Abnormalities. New York: Oxford University Press. pp. 165-203.
10. Micci F, Thorsen J, Panagopoulos I, Nyquist KB, Zeller B, Tierens A, Heim S. 2013. High-throughput sequencing identifies an NFIA/CBFA2T3 fusion gene in acute erythroid leukemia with t(1;16)(p31;q24). Leukemia 27:980-982.
11. Moore AJ, Parker RJ, Wiggins J. 2008. Malignant mesothelioma. Orphanet J Rare Dis 3:34.
12. Musti M, Kettunen E, Dragonieri S, Lindholm P, Cavone D, Serio G, Knuutila S. 2006. Cytogenetic and molecular genetic changes in malignant mesothelioma. Cancer Genet Cytogenet 170:9-15.
13. Nyquist KB, Panagopoulos I, Thorsen J, Haugom L, Gorunova L, Bjerkehagen B, Fossa A, Guriby M, Nome T, Lothe RA, Skotheim RI, Heim S, Micci F. 2012. Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma. PLoS One 7:e49705.
14. Panagopoulos I, Hoglund M, Mertens F, Mandahl N, Mitelman F, Åman P. 1996. Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene 12:489-494.
15. Panagopoulos I, Mertens F, Debiec-Rychter M, Isaksson M, Limon J, Kardas I, Domanski HA, Sciot R, Perek D, Crnalic S, Larsson O, Mandahl N. 2002a. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses. Int J Cancer 99:560-567.
16. Panagopoulos I, Mertens F, Isaksson M, Domanski HA, Brosjö O, Heim S, Bjerkehagen B, Sciot R, Dal Cin P, Fletcher JA, Fletcher CD, Mandahl N. 2002b. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer 35:340-352.
17. Plougastel B, Zucman J, Peter M, Thomas G, Delattre O. 1993. Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation. Genomics 18:609-615.
18. Riggi N, Cironi L, Suva ML, Stamenkovic I. 2007. Sarcomas: Genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J Pathol 213:4-20.
19. Sandberg AA, Bridge JA. 2001. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma. Cancer Genet Cytogenet 127:93-110.
20. Schaffer LG, Slovak ML, Campbell LJ. 2009. ISCN 2009: An International System for Human Cytogenetic Nomenclature. Basel: Karger.
21. Takeda M, Kasai T, Enomoto Y, Takano M, Morita K, Kadota E, Iizuka N, Maruyama H, Nonomura A. 2012. Genomic gains and losses in malignant mesothelioma demonstrated by FISH analysis of paraffin-embedded tissues. J Clin Pathol 65:77-82.
22. Taniguchi T, Karnan S, Fukui T, Yokoyama T, Tagawa H, Yokoi K, Ueda Y, Mitsudomi T, Horio Y, Hida T, Yatabe Y, Seto M, Sekido Y. 2007. Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32. Cancer Sci 98:438-446.
23. Thurneysen C, Opitz I, Kurtz S, Weder W, Stahel RA, Felley-Bosco E. 2009. Functional inactivation of NF2/merlin in human mesothelioma. Lung Cancer 64:140-147.
24. Zhang Q, Stovall DB, Inoue K, Sui G. 2011. The oncogenic role of Yin Yang 1. Crit Rev Oncog 16:163-197.